Aebi Schmidt Holding (AEBI)·Q4 2025 Earnings Summary

Aebi Schmidt Posts Record Order Backlog, Guides 2026 Revenue 14% Above Street

February 24, 2026 · by Fintool AI Agent

Aebi Schmidt Group (NASDAQ: AEBI) released preliminary Q4 2025 results showing Q4 net sales of $528M (+6% YoY) and a record order backlog of $1.21B. The Swiss specialty vehicles maker also provided 2026 guidance materially above Street expectations, guiding revenue of $1.95-2.15B versus consensus of $1.79B. Shares fell 5.1% intraday but surged 7% in aftermarket trading to $15.85 as investors digested the guidance upside.

Did Aebi Schmidt Meet Guidance?

Yes—slightly ahead. FY 2025 net sales of $1.907B came in at the midpoint of the $1.85-2.0B guidance range, while adjusted EBITDA is expected "slightly above" the midpoint of $145-165M guidance (~$157M implied).

Note: This is a preliminary announcement. Final Q4/FY 2025 results will be released March 19, 2026.

What Did Management Guide for 2026?

This is where the story gets interesting. Management provided 2026 guidance significantly above Street consensus:

*Values retrieved from S&P Global

The guidance assumes continued recovery in walk-in-van orders and further materialization of merger synergies from the July 2025 Shyft acquisition.

What Drove the Strong Q4 Performance?

Order momentum was exceptional. Q4 order intake surged 46% YoY, driven by:

• North America: Airport/Chassis and Municipal segments showing strength
• Walk-in-vans: Initial signs of order recovery after prolonged weakness
• Sales excellence execution: Programs at acquired Shyft businesses gaining traction

Order backlog reached a record $1.212B, up 7% from September 2025, with expected conversion to revenue within 15 months.

Regional Performance (Q4 2025)

How Did the Stock React?

The stock has had a turbulent journey since its July 2025 NASDAQ listing following the Shyft merger. After opening at $83.26, shares have declined ~82% to current levels around $14.81. The Q4 announcement initially triggered a 5.1% intraday decline, but aftermarket trading saw shares surge 7% to $15.85 as investors focused on the 2026 guidance upside.

What Changed From Last Quarter?

Several key shifts from the Q3 2025 report:

1. Walk-in-van recovery beginning: After quarters of weakness, management cited "initial signs of a recovery" in walk-in-van orders
2. Order momentum accelerating: Q4 order intake +46% YoY vs more modest growth in prior quarters
3. Europe outperformance: Europe/RoW net sales +25% YoY, significantly outpacing North America
4. H2 2026 weighted: CFO Portmann noted "pronounced quarterly seasonality in 2026 with a notably stronger second half"

What About the Board Changes?

Management also announced significant board restructuring:

Peter Spuhler, architect of the combined company and major shareholder, will be named Honorary Chairman and remains "committed long-term to the Group as the major shareholder."

Key Management Quotes

"2025 was a transformative year with the Shyft acquisition and the listing on NASDAQ, and we are optimistic about 2026. The Board updates announced today further strengthen and align our Group, as we enter the next phase toward our mid-term growth ambition." — Barend Fruithof, Group CEO

"We expect revenue conversion to ramp-up beginning in the second quarter, reflecting normal production timing, resulting in a pronounced quarterly seasonality in 2026 with a notably stronger second half of the year." — Marco Portmann, Group CFO

"Aebi Schmidt now has a strong foundation and trajectory, and it is the right time to hand over the full responsibility to the team." — Peter Spuhler, Major Shareholder

What Are the Risks?

1. Walk-in-van recovery execution: Guidance assumes continued recovery—any stall would pressure results
2. H2 weighted guidance: Significant back-half loading increases execution risk
3. Integration risk: Merger synergies must materialize as expected
4. Leverage: Company targeting <2.0x by year-end, limiting M&A flexibility

Forward Catalysts

The Bottom Line

Aebi Schmidt's preliminary Q4 showed strong order momentum (+46% YoY order intake, record backlog) and FY 2025 tracking slightly ahead of EBITDA guidance. The real story is the 2026 outlook—management guided revenue and EBITDA 14-21% above Street consensus, driving a 7% aftermarket rally despite initial intraday weakness. The path to the company's stated $3B revenue / mid-teens EBITDA margin ambition is coming into focus, though H2-weighted guidance and walk-in-van recovery execution remain key watch items.